Malignant Pharyngeal Neoplasm — Trials

Malignant Pharyngeal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,255 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 411
Recruiting: 222
Ph III recruiting: 64
Growth YoY: +6.1%
Industry share: 8%
Top sponsor: Sun Yat-sen University
Termination share: 30.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (112)

clinicaltrialsPublishedShowing 151–200 of 1,255 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03097939	Phase 2 Trial of Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma	active not recruiting	Phase 2	113	National Cancer Centre, SingaporeOTHER	1	Jun 22, 2026	clinicaltrials
NCT04965792	Post-treatment Surveillance in HPV+ Oropharyngeal SCC	active not recruiting	—	150	Dana-Farber Cancer InstituteOTHER	1	Jun 18, 2026	clinicaltrials